Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Parabolic Drugs IPO is a book build issue of ₹200.00 crores. The issue is a combination of fresh issue of 2.46 crore shares aggregating to ₹184.81 crores and offer for sale of 0.20 crore shares aggregating to ₹15.19 crores.
Parabolic Drugs IPO bidding started from Jun 14, 2010 and ended on Jun 17, 2010. The shares got listed on BSE, NSE on Jul 1, 2010.
Parabolic Drugs IPO price band is set at ₹75.00 per share . The lot size for an application is 80. The minimum amount of investment required by an retail is ₹6,000 (80 shares). The lot size investment for sNII is 34 lots (2,720 shares), amounting to ₹2,04,000, and for bNII, it is 167 lots (13,360 shares), amounting to ₹10,02,000.
The issue includes a reservation of up to 5,00,000 shares for employees offered at a discount of ₹0.00 to the issue price.
ICICI Securities Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Refer to Parabolic Drugs IPO RHP for detailed Information.
| IPO Date | June 14, 2010 to June 17, 2010 |
| Listing Date | July 1, 2010 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹75 to ₹85 per share |
| Issue Price Final | ₹75 per share |
| Lot Size | 80 Shares |
| Sale Type | Fresh Capital-cum-Offer for Sale |
| Total Issue Size | 2,66,66,667 shares (aggregating up to ₹200.00 Cr) |
| Fresh Issue | 2,46,40,965 shares (aggregating up to ₹184.81 Cr) |
| Offer for Sale | 20,25,702 shares of ₹10 (aggregating up to ₹15.19 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 3,72,51,049 shares |
| Share Holding Post Issue | 6,18,92,014 shares |
Parabolic Drugs IPO offers total 2,66,66,667 shares. Out of which 1,30,83,333 (49.06%) allocated to QIB, 39,25,000 (14.72%) allocated to NII, 91,58,334 (34.34%) allocated to RII.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 1,30,83,333 (49.06%) | NA |
| NII (HNI) Shares Offered | 39,25,000 (14.72%) | NA |
| Retail Shares Offered | 91,58,334 (34.34%) | 1,14,479 |
| Employee Shares Offered | 5,00,000 (1.87%) | NA |
| Total Shares Offered | 2,66,66,667 (100.00%) |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Parabolic Drugs IPO opens on June 14, 2010, and closes on June 17, 2010.
| IPO Open Date | Mon, Jun 14, 2010 |
| IPO Close Date | Thu, Jun 17, 2010 |
| Tentative Listing Date | Thu, Jul 1, 2010 |
| Cut-off time for UPI mandate confirmation | 5 PM on Thu, Jun 17, 2010 |
Investors can bid for a minimum of 80 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 80 | ₹6,000 |
| Retail (Max) | 33 | 2,640 | ₹1,98,000 |
| S-HNI (Min) | 34 | 2,720 | ₹2,04,000 |
| S-HNI (Max) | 166 | 13,280 | ₹9,96,000 |
| B-HNI (Min) | 167 | 13,360 | ₹10,02,000 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 1996, Parabolic Drugs Limited is in the business of manufacturing Active Pharmaceutical Ingredients (API's) and API intermediates. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.
Companies product portfolio comprises 42 APIs and 7 API intermediates which are marketed domestically and exported.
Company own and operate two manufacturing facilities at Derabassi, Punjab, and Panchkula, Haryana. Company is in the process of setting up a custom synthesis and research and development (R&D) center at Barwala, Haryana.
| Particulars | For the year/period ended (Rs. in Crore) | |||||
| 30-Sept-09 | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | 31-Mar-06 | 31-Mar-05 | |
| Total Income | 233.43 | 396.94 | 273.94 | 150.56 | 90.12 | 50.90 |
| Profit After Tax (PAT) | 12.41 | 21.09 | 29.67 | 13.58 | 8.22 | 3.27 |
The Company Parabolic Drugs IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (in Millions) |
|---|---|---|
| 1 | Multi-purpose block III at Derabassi | 203.21 |
| 2 | Sterile cephalosporin plant at Derabassi | 325.53 |
| 3 | Establishment of Chachrauli plant | 160.38 |
| 4 | Investment in our Subsidiary; | 466.24 |
| 5 | Repayment / prepayment of identified loan facilities | 388.39 |
| 6 | General corporate purposes | 175.94 |
| Listing Date | July 1, 2010 |
| BSE Script Code | 533211 |
| NSE Symbol | PARABDRUGS |
| ISIN | INE618H01016 |
| Final Issue Price | ₹75 per share |
| BSE Listing Group | B |
Parabolic Drugs Ltd.
SCO 99-100, Sector 17-B,
Chandigarh - 160017
India
Chandigarh, Chandigarh
Phone: 0172 391 4646
Email: ipo@parabolicdrugs.com
Website: http://www.parabolicdrugs.com
MUFG Intime India Pvt.Ltd.
Phone: +91-22-4918 6270
Email: pdl.ipo@linkintime.co.in
Website: https://linkintime.co.in/Initial_Offer/public-issues.html
Parabolic Drugs IPO is a main-board IPO of 2,66,66,667 equity shares of the face value of ₹10 aggregating up to ₹200.00 Crores. The issue is priced at ₹75 per share. The minimum order quantity is 80.
The IPO opens on June 14, 2010, and closes on June 17, 2010.
MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Parabolic Drugs IPO using UPI as a payment gateway. Zerodha customers can apply in Parabolic Drugs IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Parabolic Drugs IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Parabolic Drugs IPO opens on June 14, 2010 and closes on June 17, 2010.
Parabolic Drugs IPO lot size is 80, and the minimum amount required for application is ₹6,000.
You can apply in Parabolic Drugs IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Parabolic Drugs IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Parabolic Drugs IPO allotment status.
The Parabolic Drugs IPO listing date is on Thursday, July 1, 2010.
Useful Articles
RHP